DIFFERENT BINDING EPITOPES ON THE NK1 RECEPTOR FOR SUBSTANCE-P AND A NONPEPTIDE ANTAGONIST

被引:233
作者
GETHER, U
JOHANSEN, TE
SNIDER, RM
LOWE, JA
NAKANISHI, S
SCHWARTZ, TW
机构
[1] PFIZER INC, DIV CENT RES, DEPT EXPLORATORY MED CHEM, GROTON, CT 06340 USA
[2] KYOTO UNIV, FAC MED, INST IMMUNOL, KYOTO 606, JAPAN
关键词
D O I
10.1038/362345a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
NON-PEPTIDE ligands for peptide receptors have been discovered in several systems through file screening programs1-6, but the mechanism of action for these candidate drugs is obscure as they do not chemically resemble the native peptides. The compound CP 96345 is a high-affinity, non-peptide antagonist of the substance P (NK1) receptor4,5,7, which is important in pain perception and neurogenic inflammation8-11. Here we identify epitopes on the NK1 receptor responsible for the specific binding of CP 96345 by systematic exchange of corresponding segments between the NK1 receptor and the homologous NK3 (neurokinin B) receptor, which does not bind the non-peptide ligand. Non-conserved residues, in two epitopes around the top of transmembrane segment V and in one epitope at the top of transmembrane segment VI, are essential for the specific action of CP 96345 on the NK1 receptor, but are surprisingly not important for the binding of the natural peptide ligand, substance P. Susceptibility to the non-peptide antagonists can be conveyed to the previously unresponsive NK3 receptor by mutational transfer of this discontinuous epitope from the NK1 receptor.
引用
收藏
页码:345 / 348
页数:4
相关论文
共 28 条
  • [11] IVERSEN LL, 1990, ALFRED BENZON SYMP S, V29, P363
  • [12] C-TERMINAL KDEL-MODIFIED CYSTATIN-C IS RETAINED IN TRANSFECTED CHO CELLS
    JOHANSEN, TE
    VOGEL, CK
    SCHWARTZ, TW
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 172 (03) : 1384 - 1391
  • [13] BIOSYNTHESIS OF PEPTIDE PRECURSORS AND PROTEASE INHIBITORS USING NEW CONSTITUTIVE AND INDUCIBLE EUKARYOTIC EXPRESSION VECTORS
    JOHANSEN, TE
    SCHOLLER, MS
    TOLSTOY, S
    SCHWARTZ, TW
    [J]. FEBS LETTERS, 1990, 267 (02) : 289 - 294
  • [14] CHIMERIC ALPHA-2-ADRENERGIC, BETA-2-ADRENERGIC RECEPTORS - DELINEATION OF DOMAINS INVOLVED IN EFFECTOR COUPLING AND LIGAND-BINDING SPECIFICITY
    KOBILKA, BK
    KOBILKA, TS
    DANIEL, K
    REGAN, JW
    CARON, MG
    LEFKOWITZ, RJ
    [J]. SCIENCE, 1988, 240 (4857) : 1310 - 1316
  • [15] NEUROKININ-B IS A PREFERRED AGONIST FOR A NEURONAL SUBSTANCE-P RECEPTOR AND ITS ACTION IS ANTAGONIZED BY ENKEPHALIN
    LAUFER, R
    WORMSER, U
    FRIEDMAN, ZY
    GILON, C
    CHOREV, M
    SELINGER, Z
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (21) : 7444 - 7448
  • [16] MCGILLIS JP, 1990, ANN NY ACAD SCI, V594, P85
  • [17] ACTIVITY AND DISTRIBUTION OF BINDING-SITES IN BRAIN OF A NONPEPTIDE SUBSTANCE-P (NK1) RECEPTOR ANTAGONIST
    MCLEAN, S
    GANONG, AH
    SEEGER, TF
    BRYCE, DK
    PRATT, KG
    REYNOLDS, LS
    SIOK, CJ
    LOWE, JA
    HEYM, J
    [J]. SCIENCE, 1991, 251 (4992) : 437 - 439
  • [18] UNDECA-PEPTIDE AND OCTA-PEPTIDE ANTAGONISTS FOR SUBSTANCE-P, A STUDY ON THE GUINEA-PIG TRACHEA
    MIZRAHI, J
    ESCHER, E
    DORLEANSJUSTE, P
    REGOLI, D
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 99 (2-3) : 193 - 202
  • [19] PERNOW B, 1983, PHARMACOL REV, V35, P85
  • [20] DNA SEQUENCING WITH CHAIN-TERMINATING INHIBITORS
    SANGER, F
    NICKLEN, S
    COULSON, AR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (12) : 5463 - 5467